Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Ghigo

Showing results (121-130 of 455) with videos related to

Pageof 46
Sort By:
The Journal of Clinical Endocrinology and Metabolism|December 1, 1983
Defective regulation of prolactin secretion after successful removal of prolactinomasF Camanni, E Ghigo, E Ciccarelli, et al.
Journal of Endocrinological Investigation|May 17, 2007
Corticotroph axis sensitivity after exercise: comparison between elite athletes and sedentary subjectsM A Minetto, F Lanfranco, M Baldi, et al.
Journal of Endocrinological Investigation|June 18, 2003
Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenismC Di Bisceglie, L Brocato, M Tagliabue, et al.
Journal of Endocrinological Investigation|February 11, 2012
The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditionsM Filopanti, C Giavoli, S Grottoli, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1994
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in manE Ghigo, E Arvat, L Gianotti, et al.
Acta Endocrinologica|May 1, 1989
Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese childrenS Loche, C Pintor, M Cappa, et al.
Journal of Endocrinological Investigation|November 19, 1997
Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in manM Maccario, S E Oleandri, M Procopio, et al.
Clinical Endocrinology|August 10, 2000
Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's diseaseS Laureti, E Arvat, P Candeloro, et al.
Acta Endocrinologica|September 1, 1986
Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in manF Massara, E Ghigo, P Molinatti, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucoseM Maccario, M Procopio, S Grottoli, et al.
Pageof 46

Showing results (121-130 of 455) with videos related to

Sort By:
Pageof 46
The Journal of Clinical Endocrinology and Metabolism|December 1, 1983
Defective regulation of prolactin secretion after successful removal of prolactinomasF Camanni, E Ghigo, E Ciccarelli, et al.
Journal of Endocrinological Investigation|May 17, 2007
Corticotroph axis sensitivity after exercise: comparison between elite athletes and sedentary subjectsM A Minetto, F Lanfranco, M Baldi, et al.
Journal of Endocrinological Investigation|June 18, 2003
Acute goserelin administration inhibits gonadotropin and androgen secretion in post-menopausal women with ovarian hyperandrogenismC Di Bisceglie, L Brocato, M Tagliabue, et al.
Journal of Endocrinological Investigation|February 11, 2012
The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditionsM Filopanti, C Giavoli, S Grottoli, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1994
Growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, after intravenous, subcutaneous, intranasal, and oral administration in manE Ghigo, E Arvat, L Gianotti, et al.
Acta Endocrinologica|May 1, 1989
Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese childrenS Loche, C Pintor, M Cappa, et al.
Journal of Endocrinological Investigation|November 19, 1997
Comparison among the effects of arginine, a nitric oxide precursor, isosorbide dinitrate and molsidomine, two nitric oxide donors, on hormonal secretions and blood pressure in manM Maccario, S E Oleandri, M Procopio, et al.
Clinical Endocrinology|August 10, 2000
Low dose (1 microg) ACTH test in the evaluation of adrenal dysfunction in pre-clinical Addison's diseaseS Laureti, E Arvat, P Candeloro, et al.
Acta Endocrinologica|September 1, 1986
Potentiation of cholinergic tone by pyridostigmine bromide re-instates and potentiates the growth hormone responsiveness to intermittent administration of growth hormone-releasing factor in manF Massara, E Ghigo, P Molinatti, et al.
The Journal of Clinical Endocrinology and Metabolism|December 1, 1995
In obesity the somatotrope response to either growth hormone-releasing hormone or arginine is inhibited by somatostatin or pirenzepine but not by glucoseM Maccario, M Procopio, S Grottoli, et al.
Pageof 46